| Dr Connie Harris Scurti, DO | |
|
255 Baptist Blvd Ste 301, Columbus, MS 39705-2006 | |
| (662) 244-1705 | |
| (662) 227-4301 |
| Full Name | Dr Connie Harris Scurti |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 255 Baptist Blvd Ste 301, Columbus, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033449186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 26779 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Homecare Of Eupora | Eupora, MS | Home health agency |
| Kindred At Home | Columbus, MS | Home health agency |
| Baptist Memorial Hospital Golden Triangle Inc | Columbus, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Memorial Medical Group, Inc. | 5193610228 | 433 |
News Archive
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.
It's the comparative silence between the firing spikes of neurons that tells what they are really up to, scientists report.
Being overweight, especially from a young age, appears to lead to a bigger heart later in life, a condition that has been linked to serious heart problems and even death, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
Resverlogix Corp. today announced that it has initiated an exploratory Phase 2 clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.
› Verified 1 days ago
| Entity Name | Baptist Memorial Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306089206 PECOS PAC ID: 5193610228 Enrollment ID: O20101011000028 |
News Archive
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.
It's the comparative silence between the firing spikes of neurons that tells what they are really up to, scientists report.
Being overweight, especially from a young age, appears to lead to a bigger heart later in life, a condition that has been linked to serious heart problems and even death, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
Resverlogix Corp. today announced that it has initiated an exploratory Phase 2 clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Connie Harris Scurti, DO 965 Ridge Lake Blvd Ste 103, Memphis, TN 38120-9446 Ph: () - | Dr Connie Harris Scurti, DO 255 Baptist Blvd Ste 301, Columbus, MS 39705-2006 Ph: (662) 244-1705 |
News Archive
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said.
It's the comparative silence between the firing spikes of neurons that tells what they are really up to, scientists report.
Being overweight, especially from a young age, appears to lead to a bigger heart later in life, a condition that has been linked to serious heart problems and even death, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
Resverlogix Corp. today announced that it has initiated an exploratory Phase 2 clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.
› Verified 1 days ago
Fakhri Dalati, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 5th St N, Columbus, MS 39705 Phone: 662-244-2042 Fax: 662-244-2041 | |
Dr. Michael R Duckworth, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2225 5th St N, Columbus, MS 39705 Phone: 662-327-0197 Fax: 662-327-5660 | |
Michael J Boland, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd, Suite 402, Columbus, MS 39705 Phone: 662-240-1412 Fax: 662-240-1949 | |
Dr. Madhukar Saran, M.D Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 824 Alabama St, Columbus, MS 39702 Phone: 662-244-0391 Fax: 662-244-0395 | |
Dr. Paul J Scurti, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Baptist Blvd Ste 301, Columbus, MS 39705 Phone: 662-244-1705 Fax: 662-227-4301 | |
Wail Alnas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 345 Baptist Blvd, Columbus, MS 39705 Phone: 662-244-2288 Fax: 662-244-2763 |